Mapping of the acromegaly quality of life questionnaire to ED-5D-5L index score among patients with acromegaly

被引：0
作者：
Kailu Wang
Xiaopeng Guo
Siyue Yu
Lu Gao
Zihao Wang
Huijuan Zhu
Bing Xing
Shuyang Zhang
Dong Dong
机构：
[1] The Chinese University of Hong Kong,JC School of Public Health and Primary Care, Faculty of Medicine
[2] Peking Union Medical College Hospital,Department of Neurosurgery
[3] Chinese Academy of Medical Sciences and Peking Union Medical College,Key Laboratory of Endocrinology of Ministry of Health
[4] Peking Union Medical College Hospital,Department of Endocrinology
[5] Chinese Academy of Medical Sciences and Peking Union Medical College,Department of Cardiology
[6] China Pituitary Disease Registry Center,undefined
[7] China Pituitary Adenoma Specialist Council,undefined
[8] Peking Union Medical College Hospital,undefined
[9] Chinese Academy of Medical Sciences and Peking Union Medical College,undefined
[10] China Alliance of Rare Diseases,undefined
[11] Peking Union Medical College Hospital,undefined
[12] Chinese Academy of Medical Sciences and Peking Union Medical College,undefined
[13] Shenzhen Research Institute of Chinese University of Hong Kong,undefined
来源：
The European Journal of Health Economics | 2021年 / 22卷
关键词：
Mapping; Quality of life; EQ-5D; Acromegaly; AcroQoL; I19;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1381 / 1391
页数：10
相关论文
共 146 条
[1]  
Lavrentaki A(2017)Epidemiology of acromegaly: review of population studies Pituitary 20 4-9
[2]  
Paluzzi A(2012)Clinical manifestations and diagnosis of acromegaly Int. J. Endocrinol. 2012 5-32
[3]  
Wass JA(2017)Acromegaly: clinical features at diagnosis Pituitary 20 22-5376
[4]  
Karavitaki N(2004)Decreased quality of life in patients with acromegaly despite long-term cure of growth hormone excess J. Clin. Endocrinol. Metab. 89 5369-277
[5]  
Lugo G(2004)Acromegaly quality of life questionnaire (AcroQoL) Health Qual. Life Outcomes 2 13-310
[6]  
Pena L(2006)Validity and clinical applicability of the acromegaly quality of life questionnaire, AcroQoL: a 6-month prospective study Eur. J. Endocrinol. 155 269-538
[7]  
Cordido F(2008)Impaired quality of life of patients with acromegaly: control of GH/IGF-I excess improves psychological subscale appearance Eur. J. Endocrinol. 158 305-1301
[8]  
Vilar L(2015)Change in quality of life in patients with acromegaly after treatment with octreotide LAR: first application of AcroQoL in Korea BMJ Open 5 6-574
[9]  
Vilar CF(2012)Comparative effectiveness review of treatment options for pituitary microadenomas in acromegaly J. Neurosurg. 117 522-3341
[10]  
Lyra R(2017)Predictors of quality of life in acromegaly: no consensus on biochemical parameters Front. Endocrinol. 8 40-111
12345678910